Recently, adapter proteins have been shown to play a critical role in the regulation of signal transduction mediated by numerous cell surface receptors. For the past six years our laboratory has been investigating the role of adapter proteins in the control of T cell activation. During the previous two periods of support with this proposal, we identified and began the characterization of two hematopoietic specific adapter molecules: SH2 domain containing leukocyte phosphoprotein of 76kDa (SLP-76) and SLP-76 associated protein of l30kDa (SLAP-130 also known as Fyb). Evidence is accumulating supporting the notion that both of these proteins play important roles in the regulation of T cell function. The experiments described in this proposal will focus on SLAP-130/Fyb, making extensive use of a mouse we recently generated that is deficient in expression of this protein. Our preliminary data indicate that in the absence of SLAP-130/Fyb there are significant alterations in T cell function, most notably a failure of purified T cells to proliferate ex vivo and an uncoupling of the T cell antigen receptor with upregulation of integrin function. The goals of this proposal are to understand better the role of SLAP-130/Fyb in immune cell function and to investigate the structural features of this adapter protein that are critical for its function. To achieve these goals, three specific aims will be pursued. The first is to characterize thoroughly the phenotype of the SLAP-l30/Fyb deficient mice. Once the defects are clear, the second aim will investigate the structural features of SLAP-130/Fyb that are important for its function using two complementary in vivo approaches. Recognizing that, as an adapter protein, SLAP- 130/Fyb likely exerts its effects by nucleating intermolecular complexes, the third aim of this proposal will investigate the temporal and spatial organization of these complexes in cells, which appear to require SLAP-130/Fyb for their normal function. We anticipate that collectively these studies will provide new insights into how this protein (and by extension other proteins with similar functional domains) may function in the regulation of cellular activation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM053256-09
Application #
6434018
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Marino, Pamela
Project Start
1995-01-01
Project End
2005-12-31
Budget Start
2002-01-10
Budget End
2002-12-31
Support Year
9
Fiscal Year
2002
Total Cost
$324,925
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Behrens, Edward M; Koretzky, Gary A (2017) Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era. Arthritis Rheumatol 69:1135-1143
Chang, John T; Ciocca, Maria L; Kinjyo, Ichiko et al. (2011) Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division. Immunity 34:492-504
Juntilla, Marisa M; Koretzky, Gary A (2008) Critical roles of the PI3K/Akt signaling pathway in T cell development. Immunol Lett 116:104-10
Jordan, Martha S; Smith, Jennifer E; Burns, Jeremy C et al. (2008) Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76. Immunity 28:359-69
Boerth, N J; Sadler, J J; Bauer, D E et al. (2000) Recruitment of SLP-76 to the membrane and glycolipid-enriched membrane microdomains replaces the requirement for linker for activation of T cells in T cell receptor signaling. J Exp Med 192:1047-58
Boerth, N J; Judd, B A; Koretzky, G A (2000) Functional association between SLAP-130 and SLP-76 in Jurkat T cells. J Biol Chem 275:5143-52
Hunter, A J; Ottoson, N; Boerth, N et al. (2000) Cutting edge: a novel function for the SLAP-130/FYB adapter protein in beta 1 integrin signaling and T lymphocyte migration. J Immunol 164:1143-7
Myung, P S; Clements, J L; White, D W et al. (2000) In vitro and in vivo macrophage function can occur independently of SLP-76. Int Immunol 12:887-97
Fang, N; Koretzky, G A (1999) SLP-76 and Vav function in separate, but overlapping pathways to augment interleukin-2 promoter activity. J Biol Chem 274:16206-12
Peterson, E J; Latinis, K M; Koretzky, G A (1998) Molecular characterization of a CD95 signaling mutant. Arthritis Rheum 41:1047-53

Showing the most recent 10 out of 30 publications